INSL5 is a high affinity specific agonist for GPCR142 (GPR100)
about
Using paleogenomics to study the evolution of gene families: origin and duplication history of the relaxin family hormones and their receptorsEvolution of the relaxin-like peptide familyNew insights into ligand-receptor pairing and coevolution of relaxin family peptides and their receptors in teleostsThe electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformationRelaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathwaysStructure of the R3/I5 Chimeric Relaxin Peptide, a Selective GPCR135 and GPCR142 Agonist7α, 25-dihydroxycholesterol-mediated activation of EBI2 in immune regulation and diseasesSplice variants of the relaxin and INSL3 receptors reveal unanticipated molecular complexityIn vitro pharmacological characterization of RXFP3 allosterism: an example of probe dependencyInsulin-like peptide 5 is an orexigenic gastrointestinal hormoneRelaxin-3-deficient mice showed slight alteration in anxiety-related behavior.The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsA relaxin-like peptide purified from radial nerves induces oocyte maturation and ovulation in the starfish, Asterina pectinifera.Development of a selective agonist for relaxin family peptide receptor 3.Solution structure and novel insights into the determinants of the receptor specificity of human relaxin-3.International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.Constitutive formation of an RXFP1-signalosome: a novel paradigm in GPCR function and regulation.An insulin-like peptide regulates egg maturation and metabolism in the mosquito Aedes aegypti.Insulin-like peptide 5 is a microbially regulated peptide that promotes hepatic glucose production.Relaxin as a natural agent for vascular healthMechanism for insulin-like peptide 5 distinguishing the homologous relaxin family peptide receptor 3 and 4Relaxin-3/RXFP3 Signaling and Neuroendocrine Function - A Perspective on Extrinsic Hypothalamic Control.Relaxin family peptide systems and the central nervous system.A novel BRET-based binding assay for interaction studies of relaxin family peptide receptor 3 with its ligands.Distribution, physiology and pharmacology of relaxin-3/RXFP3 systems in brain.The insulinotrophic effect of insulin-like peptide 5 in vitro and in vivo.Relaxin family peptides: structure-activity relationship studies.Secretory overexpression and isotopic labeling of the chimeric relaxin family peptide R3/I5 in Pichia pastoris.A convenient method for europium-labeling of a recombinant chimeric relaxin family peptide R3/I5 for receptor-binding assays.Site-specific DOTA/europium-labeling of recombinant human relaxin-3 for receptor-ligand interaction studies.Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.Structural properties of relaxin chimeras.Relaxin signaling from natural receptors.Synthesis, conformation, and activity of human insulin-like peptide 5 (INSL5).The human gastrointestinal tract-specific transcriptome and proteome as defined by RNA sequencing and antibody-based profiling.The highly conserved negatively charged Glu141 and Asp145 of the G-protein-coupled receptor RXFP3 interact with the highly conserved positively charged arginine residues of relaxin-3.Design and recombinant expression of insulin-like peptide 5 precursors and the preparation of mature human INSL5.R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization.Structural insights into the function of relaxins.Recombinant expression of an insulin-like peptide 3 (INSL3) precursor and its enzymatic conversion to mature human INSL3.
P2860
Q21134735-C441BB1F-FD26-4209-9F7B-1B648AD25C75Q21283971-D5BB6C76-970C-44FB-81D5-576135D4F8DDQ21296667-86AC98E5-A343-400B-A177-E745B400E4C5Q24297116-DCF3FA1C-16DC-4D63-80A3-0B767160742CQ24564959-0C469DE8-16E0-409C-9542-1D42EF51E6D1Q27650936-4A8EBE5F-5AD7-4B7B-96F3-FA9E07D888DAQ28083491-721D3E7B-C986-45E9-A3F2-0028818A776AQ28264243-82B652F4-2622-423E-8D34-4673B3BEBD0BQ28480533-456B6B41-B5EF-4057-9589-92BF0DD3199AQ28507260-87D831B6-1541-4654-B2CE-3561FB89B21EQ30474290-69257BE8-0A44-4392-AD22-E66F89956E69Q30486707-995C89D5-A856-4AA0-BC77-05912CACB65DQ30487747-886E9132-BC31-43BD-8DD0-D77DFCA650E7Q33789534-DC769EF8-9B37-42C9-9178-C1EC90A42E01Q34478007-F7EA9C25-2E57-4D1A-8FF4-1E4CFEED678DQ35383835-CD3C6465-A049-454B-B38E-6A0450A7F3B6Q36025314-85A362DE-6EA1-46BC-973D-F0611C8828AEQ36558126-61061EDF-40C7-477F-A071-18E5B01D5DE2Q36740460-9BF46DBC-F4BB-495F-8EC2-ADE1E00414FBQ36835818-183984C8-29F2-40AF-8652-ED60109FF727Q37081723-D37760F7-D9BB-412C-9A2B-9C72306256B8Q37180057-C9F1C5BA-216E-46FF-B69D-4FAF66A84F27Q37705025-CD94EB39-14C4-44DA-8AEB-46DAA5E3A6B8Q38761448-908D7794-C616-4190-8E5F-496BCF955FD4Q38806835-387F5DF0-031A-4A5D-BE6D-9CB271021360Q38928000-12C262EA-988A-4DA4-B37E-35B7A3F2D6C9Q39030385-8CC0B7A7-D623-4BEE-B695-1BC11C1DD29AQ39032858-62D41E6C-AE50-4051-B840-4E674CA42F6AQ39445866-E2B9576B-5A07-4780-B823-C9FD89879269Q39673607-B38C7AC9-B68A-4571-809C-BE3E041F76EEQ39982334-8A55CFC2-EB1F-4BDD-AC5C-5A068CDBF6B4Q39982342-926350A5-7BED-45C9-BE58-8DB31ABE78B5Q40409527-952E8601-D703-4AEB-B2B8-B0C1DF2C9DB1Q41335251-4299F33A-2255-49CD-8669-9666A72F9942Q42658326-68ED4E15-E674-4C0C-B461-7B265F0B16C7Q43592780-62F6E102-6410-4E79-8D5B-68A16C42267FQ43665074-A5123D11-3B47-42FF-A7AF-900CBBF77C3EQ44414360-7F44F17E-DFBE-4304-9D48-C7D68059FAB5Q44918712-A9C9A8E1-9628-4CD6-A7FC-7822FCD6523BQ45111906-50AECE41-ADB9-4011-B9DE-895512C2C72F
P2860
INSL5 is a high affinity specific agonist for GPCR142 (GPR100)
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
INSL5 is a high affinity specific agonist for GPCR142 (GPR100)
@ast
INSL5 is a high affinity specific agonist for GPCR142 (GPR100)
@en
INSL5 is a high affinity specific agonist for GPCR142 (GPR100)
@nl
type
label
INSL5 is a high affinity specific agonist for GPCR142 (GPR100)
@ast
INSL5 is a high affinity specific agonist for GPCR142 (GPR100)
@en
INSL5 is a high affinity specific agonist for GPCR142 (GPR100)
@nl
prefLabel
INSL5 is a high affinity specific agonist for GPCR142 (GPR100)
@ast
INSL5 is a high affinity specific agonist for GPCR142 (GPR100)
@en
INSL5 is a high affinity specific agonist for GPCR142 (GPR100)
@nl
P2093
P2860
P3181
P356
P1476
INSL5 is a high affinity specific agonist for GPCR142 (GPR100)
@en
P2093
Changlu Liu
Chester Kuei
Da-Thao Tran
Diane Nepomuceno
Elo Eriste
Fredrik Kamme
Jessica Zhu
Jingcai Chen
Pascal Bonaventure
P2860
P304
P3181
P356
10.1074/JBC.M409916200
P407
P577
2005-01-07T00:00:00Z